Geovax Labs (Geovax Labs) Price-to-Tangible-Book : (As of May. 12, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Geovax Labs Price-to-Tangible-Book?

As of today (2024-05-12), Geovax Labs's share price is $0.035. Geovax Labs's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.00. Hence, Geovax Labs's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Geovax Labs's Price-to-Tangible-Book or its related term are showing as below:

GOVXW' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.54 Med: 3.58 Max: 4664998.93
Current: 0.54

During the past 13 years, Geovax Labs's highest Price to Tangible Book Ratio was 4664998.93. The lowest was 0.54. And the median was 3.58.

GOVXW's Price-to-Tangible-Book is ranked better than
93.61% of 1221 companies
in the Biotechnology industry
Industry Median: 2.7 vs GOVXW: 0.54

A closely related ratio is called PB Ratio. As of today, Geovax Labs's share price is $0.035. Geovax Labs's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.00. Hence, Geovax Labs's P/B Ratio of today is .

Geovax Labs Price-to-Tangible-Book Historical Data

The historical data trend for Geovax Labs's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geovax Labs Price-to-Tangible-Book Chart

Geovax Labs Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

Geovax Labs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Geovax Labs's Price-to-Tangible-Book

For the Biotechnology subindustry, Geovax Labs's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Geovax Labs's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Geovax Labs's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Geovax Labs's Price-to-Tangible-Book falls into.

Geovax Labs Price-to-Tangible-Book Calculation

Geovax Labs's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.035	/
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Geovax Labs Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Geovax Labs's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Geovax Labs (Geovax Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Geovax Labs Inc (NAS:GOVXW) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

GOVX:USA E8L:Germany

Address

1900 Lake Park Drive, Suite 380, Smyrna, GA, USA, 30080

Website

https://www.geovax.com

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.